PLMR Q3 Earnings Beat Estimates on Strong Premium Growth

Palomar reported Q3 adjusted EPS of $3.01, beating the $2.60 consensus by 15.8%, while revenue rose 58% year over year to $386.6 million and gross written premiums increased 28.4% to $767 million. It raised 2026 adjusted net income guidance to $280–$285 million from $270–$280 million, despite higher claims and underwriting costs; the combined ratio deteriorated 270 basis points to 80.8%. Palomar also repurchased 70,000 shares for $8.9 million and declared a quarterly dividend of $0.45 per share.

Analysis

The beat is less clean than headline growth suggests: premium scale is expanding, but the 920 bp rise in the loss ratio—especially the higher attritional component—makes underwriting quality the key valuation variable. The improved expense ratio is helping absorb that pressure; if it reverses as the book scales, premium growth could translate into less incremental profit than guidance implies. Crop now represents a meaningful exposure, so a single quarter is not enough to distinguish mix/seasonality from adverse loss selection; verify segment-level loss emergence and reinsurance economics.

Near term, guidance raised and strong adjusted ROE support sentiment, but earnings also benefit from a larger invested-asset base and higher yields. Over 1–3 months, rate expectations and the next loss-development disclosures matter more than the headline premium run rate. Over 6–18 months, sustained attritional deterioration or a turn in specialty pricing would challenge the growth multiple; lower reinvestment yields would also temper investment-income support. The wider weakness in underwriting metrics at Chubb and catastrophe burden at Arch point to sector-wide claims sensitivity, not proof that Palomar’s exposures are equivalent.

Contrarian read: growth and the raised outlook may be over-rewarded if investors treat this as pure underwriting leverage. Conversely, the combined ratio remains profitable, so one adverse quarter does not establish a broken model. Valuation and post-release price action are not supplied; avoid an unconditional chase.

Key Decisions for Investors

• Prefer a measured long PLMR on post-earnings weakness rather than buying a gap higher; scale only if subsequent disclosures show attritional losses stabilizing and guidance delivery remains on track. Falsify if the loss ratio continues to deteriorate or management cuts the 2026 outlook.
• For the next 1–3 months, monitor crop and surety loss emergence, renewal/pricing commentary, and the bridge from gross to net premiums. Treat rapid premium growth without stable underwriting results as a warning, not an automatic bullish signal.
• Keep exposure sized for rate sensitivity: a fall in reinvestment yields could reduce the contribution from investment income as the portfolio turns over. Track investment income and average invested assets against rate moves.
• No clean peer pair is warranted from these results alone: PLMR, Arch Capital Group (ACGL), and Chubb (CB) have materially different business mixes, while NMI Holdings (NMIH) is not a direct underwriting comparable. Require valuation and segment-level data before expressing a relative-value position.